KR101602629B1 - Producing method of a composition with orobol for treating wrinkled skin - Google Patents
Producing method of a composition with orobol for treating wrinkled skin Download PDFInfo
- Publication number
- KR101602629B1 KR101602629B1 KR1020150044622A KR20150044622A KR101602629B1 KR 101602629 B1 KR101602629 B1 KR 101602629B1 KR 1020150044622 A KR1020150044622 A KR 1020150044622A KR 20150044622 A KR20150044622 A KR 20150044622A KR 101602629 B1 KR101602629 B1 KR 101602629B1
- Authority
- KR
- South Korea
- Prior art keywords
- orobol
- weight
- composition
- skin wrinkles
- cosmetic composition
- Prior art date
Links
- IOYHCQBYQJQBSK-UHFFFAOYSA-N orobol Chemical compound C=1C(O)=CC(O)=C(C2=O)C=1OC=C2C1=CC=C(O)C(O)=C1 IOYHCQBYQJQBSK-UHFFFAOYSA-N 0.000 title claims abstract description 97
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 238000000034 method Methods 0.000 title claims description 5
- 230000037303 wrinkles Effects 0.000 claims abstract description 43
- 239000002537 cosmetic Substances 0.000 claims abstract description 28
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 claims abstract description 26
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000006539 genistein Nutrition 0.000 claims abstract description 21
- 229940045109 genistein Drugs 0.000 claims abstract description 21
- 102000004020 Oxygenases Human genes 0.000 claims abstract description 6
- 108090000417 Oxygenases Proteins 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims description 9
- 239000000839 emulsion Substances 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 4
- 239000003921 oil Substances 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 239000006072 paste Substances 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 235000013305 food Nutrition 0.000 abstract description 12
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 abstract description 10
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 8
- 102000003425 Tyrosinase Human genes 0.000 abstract description 5
- 108060008724 Tyrosinase Proteins 0.000 abstract description 5
- 239000008213 purified water Substances 0.000 abstract description 3
- 239000000470 constituent Substances 0.000 abstract 4
- 230000001603 reducing effect Effects 0.000 abstract 4
- 238000006703 hydration reaction Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 39
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 21
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 16
- 235000008696 isoflavones Nutrition 0.000 description 16
- 239000002609 medium Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- DDKGKOOLFLYZDL-UHFFFAOYSA-N 3',4',7-trihydroxyisoflavone Chemical compound C=1C(O)=CC=C(C2=O)C=1OC=C2C1=CC=C(O)C(O)=C1 DDKGKOOLFLYZDL-UHFFFAOYSA-N 0.000 description 13
- BMZFZTMWBCFKSS-UHFFFAOYSA-N 8-Hydroxydaidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=C(O)C(O)=CC=C2C1=O BMZFZTMWBCFKSS-UHFFFAOYSA-N 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 150000002515 isoflavone derivatives Chemical class 0.000 description 9
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 8
- -1 glycerol aliphatic ester Chemical class 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 7
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 7
- 235000013334 alcoholic beverage Nutrition 0.000 description 7
- 235000007240 daidzein Nutrition 0.000 description 7
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 229930195712 glutamate Natural products 0.000 description 7
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 7
- ADFCQWZHKCXPAJ-GFCCVEGCSA-N equol Chemical compound C1=CC(O)=CC=C1[C@@H]1CC2=CC=C(O)C=C2OC1 ADFCQWZHKCXPAJ-GFCCVEGCSA-N 0.000 description 6
- 235000019126 equol Nutrition 0.000 description 6
- ADFCQWZHKCXPAJ-UHFFFAOYSA-N indofine Natural products C1=CC(O)=CC=C1C1CC2=CC=C(O)C=C2OC1 ADFCQWZHKCXPAJ-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- GYLUFQJZYAJQDI-UHFFFAOYSA-N 4',6,7-trihydroxyisoflavone Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=C(O)C=C2C1=O GYLUFQJZYAJQDI-UHFFFAOYSA-N 0.000 description 5
- ZCOLJUOHXJRHDI-FZHKGVQDSA-N Genistein 7-O-glucoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)c1cc(O)c2C(=O)C(c3ccc(O)cc3)=COc2c1 ZCOLJUOHXJRHDI-FZHKGVQDSA-N 0.000 description 5
- CJPNHKPXZYYCME-UHFFFAOYSA-N Genistin Natural products OCC1OC(Oc2ccc(O)c3OC(=CC(=O)c23)c4ccc(O)cc4)C(O)C(O)C1O CJPNHKPXZYYCME-UHFFFAOYSA-N 0.000 description 5
- YCUNGEJJOMKCGZ-UHFFFAOYSA-N Pallidiflorin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC(O)=C2C1=O YCUNGEJJOMKCGZ-UHFFFAOYSA-N 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000003013 cytotoxicity Effects 0.000 description 4
- 231100000135 cytotoxicity Toxicity 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 235000003642 hunger Nutrition 0.000 description 4
- 210000002510 keratinocyte Anatomy 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- 229960003471 retinol Drugs 0.000 description 4
- 235000020944 retinol Nutrition 0.000 description 4
- 239000011607 retinol Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 230000037351 starvation Effects 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical class NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000005805 hydroxylation reaction Methods 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 241001107116 Castanospermum australe Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 2
- 244000131316 Panax pseudoginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 235000021279 black bean Nutrition 0.000 description 2
- 235000007215 black sesame Nutrition 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229930013032 isoflavonoid Natural products 0.000 description 2
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 2
- 235000012891 isoflavonoids Nutrition 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 231100000956 nontoxicity Toxicity 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000013580 sausages Nutrition 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 239000004470 DL Methionine Substances 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- IAQRGUVFOMOMEM-UHFFFAOYSA-N butene Natural products CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000019990 fruit wine Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- FVIZARNDLVOMSU-UHFFFAOYSA-N ginsenoside K Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O FVIZARNDLVOMSU-UHFFFAOYSA-N 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical class OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229940016409 methylsulfonylmethane Drugs 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- MAYUCBCSAVDUKG-UHFFFAOYSA-N orthoacetic acid Chemical compound CC(O)(O)O MAYUCBCSAVDUKG-UHFFFAOYSA-N 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- YXJHJCDOUFKMBG-BMZHGHOISA-M riboflavin sodium Chemical compound [Na+].OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)[N-]C2=O YXJHJCDOUFKMBG-BMZHGHOISA-M 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 235000019997 soju Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A23L1/30—
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/30—Other Organic compounds
Abstract
Description
본 발명은 오로볼(orobol)을 유효성분으로 함유하는 피부 주름 개선용 조성물에 관한 것으로, 더욱 상세하게는 오로볼을 유효성분으로 함유하는 피부 주름 개선용 식품 조성물 및 화장료 조성물에 관한 것이다.
The present invention relates to a composition for improving skin wrinkles containing orobol as an active ingredient, and more particularly to a food composition and a cosmetic composition for improving skin wrinkles containing ourobol as an active ingredient.
피부는 표피, 진피 및 피하지방으로 이루어진 몸의 외피로서, 다양한 환경적인 요인에 대해 신체를 보호하는 물리적 장벽의 기능, 촉각 및 온도 조절 등의 역할을 한다. 그런데, 산업화된 현대 사회에서는 서구화된 생활습관, 스트레스 및 환경오염으로부터 야기되는 자외선 양의 증가로 인해 피부를 손상 및 노화를 야기시키고 있다. 피부의 노화는 시간이 지남에 따라 호르몬 분비가 감소하고, 면역세포의 기능과 활성이 저하되어 생체 구성 단백질들의 생합성이 줄어들게 되어 유발되는 내인성 노화와 오염된 공기, 약물이나 자외선 등에 의한 외인성 노화로 나뉜다 (Park HR et al., Journal of Investigative Cosmetology. 7: 115-122. 2011).The skin is the outer skin of the body consisting of epidermis, dermis and subcutaneous fat. It functions as a physical barrier to protect the body against various environmental factors, tactile sensation and temperature control. However, in modern industrialized society, westernized lifestyle, stress, and the increase in the amount of ultraviolet rays caused by environmental pollution are causing damage and aging of the skin. The aging of the skin is divided into endogenous aging caused by decrease of hormone secretion, immune cell function and activity decrease, biosynthetic protein biosynthesis is reduced, and exogenous aging by contaminated air, drug or ultraviolet ray (Park HR et al ., Journal of Investigative Cosmetology . 7: 115-122. 2011).
외인성 노화중에서도 특히, 자외선은 피부 표면 각질층의 유연성을 상실시키고, 피부가 건성이 되게 하며, 거칠어지게 만든다. 또한, 자외선은 교원질의 합성을 감소시키며 세포외 기질 단백질 분해 효소인 'MMPs(matrix metalloproteinase)' 발현을 증가시킨다 (Jin Young Seo et al., Korean Journal of Investigative Dermatology. 8(4):187-194. 2001). 이로 인해 피부 내 교원질의 양이 부족해지고 탄력섬유가 변성되면서 주름살이 생기게 된다.Particularly in extrinsic aging, ultraviolet light loses the flexibility of the stratum corneum on the skin surface, makes the skin dry, and makes it rough. In addition, UV rays are thereby reduces the synthesis of collagen increases the extracellular matrix protease, the 'MMPs (matrix metalloproteinase)' expression (Jin Young Seo et al, Korean Journal of Investigative Dermatology 8 (4):.. 187-194 2001). As a result, the amount of collagen in the skin becomes insufficient and the elastic fibers are denatured, resulting in wrinkles.
이러한, 피부 주름을 개선시키기 위해 가장 많이 사용되는 것으로는 레티놀 (retinol)이 있다. 레티놀(retinol)은 주름 기능성 식약처 고시형 원료로써 표피세포의 분화 및 재생을 조절한다고 알려져 있다 (Griffiths CE et al., The New England Jornal of Medicine. 329(8):530-535). 그러나, 레티놀의 경우, 효과는 우수하지만 열 안정성이 낮아 열을 가했을 때 변형이 쉽고, 독성이 높아 피부자극을 유발하는 문제가 있다. 레티놀의 불안정성을 해결하기 위해, 최근에는 'ECM(Extra-Cellular Matrix)' 조절 성분으로 작약에서 추출한 파에오니플로린(paeoniflorin), 인삼 내에 존재하는 컴파운드 K(compound K) 등 다양한 천연 물질들이 피부 주름 개선 소재로 사용되고 있다. Retinol is the most commonly used to improve skin wrinkles. Retinol is known to modulate the differentiation and regeneration of epidermal cells as a wrinkle-functioning drug substance (Griffiths CE et al. , The New England Journal of Medicine 329 (8): 530-535). However, in the case of retinol, the effect is excellent, but the thermal stability is low, so that it is easily deformed when heat is applied, and toxicity is high, which causes skin irritation. In order to solve the instability of retinol, various natural substances such as paeoniflorin and compound K existing in ginseng, which are extracted from peony as an ECM (Extra-Cellular Matrix) control ingredient, It is used as material.
그러나, 이러한 물질의 원료가 되는 작약과 인삼의 경우, 가격이 비싸 가격 경쟁력에서 취약하다는 단점이 존재한다. 피부 주름 개선용 식품 및 화장품 조성물의 경우 지속적인 원료의 공급 및 확보가 가능해야한다는 점에서 가격 경쟁력을 가지면서도 효능이 뛰어난 생리활성 물질의 개발이 이루어져야 한다.However, there is a disadvantage in that peanut and ginseng, which are raw materials of these substances, are expensive and vulnerable to price competition. In the case of food wrinkles and cosmetic compositions for improving skin wrinkles, it is necessary to develop and supply physiologically active substances having high price competitiveness and high efficacy in order to continuously supply and secure raw materials.
한편, 오로볼(orobol)은 이소플라본의 한 종류로, 이는 콩에 함유되어 있으며, 정확한 분자식은 3-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one이고, 분자량은 286.23 g/mol이다. 오로볼은 제니스테인(genistein)과 다이드제인(daidzein)과 같이 콩에 함유된 주된 이소플라본으로, 모노페놀형 구조로 존재한다. 오로볼의 경우에는 모노페놀형 구조 물질의 오르토(ortho-) 위치에 수산화기가 하나 더 도입이 된 구조를 이루고 있다.
On the other hand, orobol is a kind of isoflavone, which is contained in soybean, and its precise molecular formula is 3- (3,4-dihydroxyphenyl) -5,7-dihydroxychromen-4-one and its molecular weight is 286.23 g / mol. Orobolt is a major isoflavone contained in soy, such as genistein and daidzein, which is present as a monophenol-like structure. In the case of Orobor, one hydroxyl group is introduced at the ortho-position of the monophenol-type structural material.
본 발명은 피부 주름 개선에 효과가 있는 천연물질을 새롭게 발굴하여 피부 주름 개선용 식품 조성물 및 화장료 조성물을 제공하는 것을 목적으로 한다.
It is an object of the present invention to provide a food composition for improving skin wrinkles and a cosmetic composition by newly discovering a natural substance which is effective for improving skin wrinkles.
본 발명은 하기 화학식 1 로 표시되는 오로볼(orobol)을 유효성분으로 함유하는 것을 특징으로 하는 피부 주름 개선용 식품 조성물을 제공한다. 상기 오로볼은 하기 실험예를 통해 제니스테인, 다이드제인, 제니스틴, 다이드진, 6,7,4'-trihydroxyisoflavone(6-ODI), 7,3',4'-trihydroxyisoflavone(3'-ODI), 7,8,4'-trihydroxyisoflavone(8-ODI), 에쿠올(equol)와 같은 다른 이소플라본 보다 피부 주름 개선 효과가 우수한 것을 확인하였다. The present invention provides a food composition for improving skin wrinkles, which comprises orobol represented by the following formula (1) as an active ingredient. The above-mentioned Orovall can be produced by the following experimental examples, such as genistein, daidzein, genistin, daidzin, 6,7,4'-trihydroxyisoflavone (6-ODI), 7,3 ', 4'- trihydroxyisoflavone , 7,8,4'-trihydroxyisoflavone (8-ODI), and equol.
[화학식 1][Chemical Formula 1]
본 발명의 피부 주름 개선용 식품 조성물에 있어서, 상기 오로볼(orobol)은 콩에 함유된 이소플라본 중에 하나로, 이소플라본 내에 존재하는 것으로 알려져 있다. In the food composition for improving skin wrinkles of the present invention, it is known that the orobol is present in isoflavone as one of the isoflavones contained in the soybean.
또한, 상기 오로볼은 일 예로, 아스페르길루스 니게르(Aspergillus niger)', 'Steptomyces neyagawaenis'를 통해 분리한 것을 사용할 수 있고 (Tomanaga et al, 182(2):31, 1992), 이소플라본 중 제니스테인(genistein)에 위치 특이적 수산화 반응을 일으킬 수 있는 옥시게나아제(oxygenase (P450, tyrosinase))를 사용하여, 3-수산화 반응을 일으켜 'ortho-' 위치에 수산화기가 첨가된 오로볼(orobol)을 대량 생산하여 사용할 수도 있다. In addition, the above-mentioned Orobol can be, for example, Aspergillus niger 'and' Steptomyces neyagawaenis ' (Tomanaga et al. , 182 (2): 31, 1992), using an oxygenase (P450, tyrosinase) capable of causing a site-specific hydroxylation reaction in isoflavones genistein, It is also possible to mass-produce orobol with hydroxyl group at the 'ortho-' position.
본 발명의 피부 주름 개선용 식품 조성물에 있어서, 상기 오로볼은 바람직하게 농도가 1 μM~1 mM인 것이 좋으며, 더욱 바람직하게는 1~20 μM인 것이 좋다. 오로볼의 농도가 20 μM을 초과할 경우, 독성이 생기고, 1 μM일 경우, 피부 주름 개선 효과가 미미하다. 따라서, 1~20 μM 범위를 만족할 시, 독성이 없고 우수한 피부 주름 개선 효과를 발휘한다.In the skin wrinkle improving food composition of the present invention, it is preferable that the oolop has a concentration of 1 μM to 1 mM, more preferably 1 to 20 μM. When the concentration of the ouroborate is more than 20 μM, the toxicity is produced. When the concentration is 1 μM, the effect of improving the wrinkles of the skin is insignificant. Therefore, when the range of 1 to 20 μM is satisfied, there is no toxicity and excellent wrinkle improving effect is exhibited.
또한, 본 발명의 피부 주름 개선용 식품 조성물에 있어서, 상기 오로볼은 바람직하게 식품 조성물 대비 0.1~50 중량% 포함되는 것이 좋다. 상기 범위가 0.1 중량% 이하일 경우, 피부 주름 개선 효과가 미미하고 50 중량% 이상일 경우, 경제적이지 못하다.Further, in the food composition for improving skin wrinkles of the present invention, it is preferable that the above-mentioned oolop be contained in an amount of 0.1 to 50% by weight relative to the food composition. When the above range is 0.1% by weight or less, the effect of improving skin wrinkles is insignificant, and when it is 50% by weight or more, it is not economical.
본 발명의 피부 주름 개선용 식품 조성물은 일예로, 육류, 곡류, 카페인 음료, 일반음료, 초콜렛, 빵류, 스낵류, 과자류, 사탕, 피자, 젤리, 면류, 껌류, 유제품류, 아이스크림류, 알코올성 음료, 술, 비타민 복합제 및 그 밖의 건강보조식품류 중 선택되는 어느 하나일 수 있다.
The composition for improving skin wrinkles of the present invention can be used as a food composition for improving the skin wrinkles in a variety of ways such as meat, cereal, caffeinated beverages, general beverages, chocolate, bread, snacks, confectionery, candy, pizza, jelly, Alcoholic beverages, alcoholic beverages, alcoholic beverages, alcoholic beverages, alcoholic beverages, alcoholic beverages, alcoholic beverages,
한편, 본 발명은 상기 화학식 1 로 표시되는 오로볼(orobol)을 유효성분으로 함유하는 것을 특징으로 하는 피부 주름 개선용 화장료 조성물을 제공한다. 상기 오로볼은 하기 실험예를 통해 제니스테인, 다이드제인, 제니스틴, 다이드진, 6,7,4'-trihydroxyisoflavone(6-ODI), 7,3',4'-trihydroxyisoflavone(3'-ODI), 7,8,4'-trihydroxyisoflavone(8-ODI), 에쿠올(equol)와 같은 다른 이소플라본 보다 피부 주름 개선 효과가 우수한 것을 확인하였다.The present invention also provides a cosmetic composition for improving skin wrinkles, which comprises orobol represented by the formula (1) as an active ingredient. The above-mentioned Orovall can be produced by the following experimental examples, such as genistein, daidzein, genistin, daidzin, 6,7,4'-trihydroxyisoflavone (6-ODI), 7,3 ', 4'- trihydroxyisoflavone , 7,8,4'-trihydroxyisoflavone (8-ODI), and equol.
본 발명의 피부 주름 개선용 화장료 조성물에 있어서, 상기 오로볼(orobol)은 콩에 함유된 이소플라본 중에 하나로, 이소플라본 내에 존재하는 것으로 알려져 있다. In the cosmetic composition for improving skin wrinkles of the present invention, it is known that the orobol is present in the isoflavone as one of the isoflavones contained in the soybean.
또한, 상기 오로볼은 일 예로 아스페르길루스 니게르(Aspergillus niger)', 'Steptomyces neyagawaenis'을 통해 분리한 것일 수 있고 (Tomanaga et al, 182(2):31, 1992), 이소플라본 중 제니스테인(genistein)에 위치 특이적 수산화 반응을 일으킬 수 있는 옥시게나아제(oxygenase(P450, tyrosinase))를 사용하여, 3-수산화 반응을 일으켜 'ortho-' 위치에 수산화기가 첨가되어 대량생산된 오로볼(orobol)일 수도 있다.In addition, the above- mentioned Orobol can be isolated through Aspergillus niger , Steptomyces neyagawaenis (Tomanaga et al. , 182 (2): 31, 1992), using an oxygenase (P450, tyrosinase) capable of causing a site-specific hydroxylation reaction in isoflavones genistein, It may also be a mass produced orobol with the addition of hydroxyl groups at the 'ortho-' position.
본 발명의 피부 주름 개선용 화장료 조성물에 있어서, 상기 오로볼은 바람직하게 농도가 1 μM~1 mM인 것이 좋으며, 더욱 바람직하게는 1~20 μM인 것이 좋다. 오로볼의 농도가 20 μM를 초과할 경우, 독성이 생기고, 1 μM일 경우, 피부 주름 개선 효과가 미미하다. 따라서, 1~20 μM 범위를 만족할 시, 독성이 없고 우수한 피부 주름 개선 효과를 발휘한다.In the cosmetic composition for improving skin wrinkles of the present invention, the oolop preferably has a concentration of 1 μM to 1 mM, more preferably 1 to 20 μM. When the concentration of the Oroborate is more than 20 μM, the toxicity is produced. When the concentration is 1 μM, the effect of improving the wrinkles of the skin is insignificant. Therefore, when the range of 1 to 20 μM is satisfied, there is no toxicity and excellent wrinkle improving effect is exhibited.
또한, 본 발명의 피부 주름 개선용 화장료 조성물에 있어서, 상기 오로볼은 바람직하게 화장료 조성물 대비 0.1~50 중량% 포함되는 것이 좋다. 상기 범위가 0.1 중량% 이하일 경우, 피부 주름 개선 효과가 미미하고 50 중량% 이상일 경우, 경제적이지 못하다.Further, in the cosmetic composition for improving skin wrinkles of the present invention, it is preferable that the oolop is contained in an amount of 0.1 to 50% by weight relative to the cosmetic composition. When the above range is 0.1% by weight or less, the effect of improving skin wrinkles is insignificant, and when it is 50% by weight or more, it is not economical.
본 발명의 피부 주름 개선용 화장료 조성물은 일예로, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제 함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 팩, 마사지크림 및 스프레이 중 선택되는 어느 하나일 수 있다.The cosmetic composition for improving skin wrinkles of the present invention may be in the form of a suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing oil, powder foundation, emulsion foundation, wax foundation, Cream, and spray.
한편, 본 발명의 화장료 조성물의 제형이 상기 페이스트 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라가칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.On the other hand, when the formulation of the cosmetic composition of the present invention is the above paste or gel, the carrier component may be an animal oil, a vegetable oil, a wax, a paraffin, a starch, a tragacanth, a cellulose derivative, polyethylene glycol, silicone, bentonite, silica, Zinc and the like can be used.
한편, 본 발명의 화장료 조성물의 제형이 상기 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.On the other hand, when the formulation of the cosmetic composition of the present invention is the powder or the spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, Propellants such as fluorohydrocarbons, propane / butane or dimethyl ether.
한편, 본 발명의 화장료 조성물의 제형이 상기 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제로 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 이용될 수 있다.On the other hand, when the formulation of the cosmetic composition of the present invention is the above solution or emulsion, the carrier component may be water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol , 1,3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid esters of sorbitan can be used.
한편, 본 발명의 화장료 조성물의 제형이 상기 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라가칸트 등이 이용될 수 있다.On the other hand, when the formulation of the cosmetic composition of the present invention is the suspension, a liquid diluent such as water, ethanol or propylene glycol, ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester, polyoxyethylene sorbitan ester, Microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tragacanth, and the like may be used.
한편, 본 발명의 화장료 조성물의 제형이 상기 계면활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.On the other hand, when the formulation of the cosmetic composition of the present invention is the above-mentioned surfactant-containing cleansing agent, alcohols such as aliphatic alcohol sulfates, aliphatic alcohol ether sulfates, sulfosuccinic acid monoesters, isethionates, imidazolinium derivatives, Fatty acid amide ether sulfate, alkylamido betaine, aliphatic alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, lanolin derivative, or ethoxylated glycerol fatty acid ester.
한편, 본 발명의 화장료 조성물은 단독 또는 중복하여 사용하거나, 본 발명 이외의 다른 화장료 조성물과 중복하여 사용할 수 있다. 또한, 본 발명에 따른 화장료 조성물은 통상적인 사용방법에 따라 사용될 수 있으며, 사용자의 피부 상태 또는 취향에 따라 그 사용횟수를 달리할 수도 있다.
On the other hand, the cosmetic composition of the present invention may be used singly or in combination, or may be used in combination with other cosmetic compositions other than the present invention. In addition, the cosmetic composition according to the present invention can be used according to a conventional method of use, and may be used in a different number of times depending on the skin condition or taste of the user.
본 발명의 피부 주름 개선용 조성물에 함유된 오로볼(orobol)은 주름을 유발하는 MMP-1 발현을 감소시켜, 우수한 피부 주름 개선 효과를 발휘한다.
The orobol contained in the composition for improving skin wrinkles of the present invention reduces the expression of MMP-1 causing wrinkles and exerts excellent skin wrinkle-reducing effect.
도 1은 오로볼 농도별 세포 독성평가 결과로, 레인 1은 대조군, 레인 2는 오로볼(orobol) 2.5 μM 처리군, 레인 3은 오로볼(orobol) 5 μM 처리군, 레인 4는 오로볼(orobol) 10 μM 처리군, 레인 5는 오로볼(orobol) 20 μM 처리군, 레인 6은 오로볼(orobol) 40 μM 처리군, 레인 7은 오로볼(orobol) 80 μM 처리군이다.
도 2는 자외선에 의한 MMP-1 단백질 발현 평가 실험 결과로, 레인 1은 대조군, 레인 2는 SUV(solar ultra violet) 20 kJ/m2 처리군, 레인 3은 오로볼(orobol) 1 μM 에 SUV 20 kJ/m2 처리군, 레인 4는 오로볼(orobol) 2 μM 에 SUV 20 kJ/m2 처리군, 레인 5는 오로볼(orobol) 4 μM 에 SUV 20kJ/m2 처리군, 레인 6은 제니스테인(genistein) 1 μM 에 SUV 20 kJ/m2 처리군, 레인 7은 제니스테인(genistein) 2 μM 에 SUV 20 kJ/m2 처리군, 레인 8은 제니스테인(genistein) 4 μM 에 SUV 20 kJ/m2 처리군이다.
도 3은 오로볼과 이소플라본 8종의 MMP-1 단백질 발현 정도를 비교한 실험 결과로, 레인 1은 대조군, 레인 2는 SUV 20 kJ/m2 처리군, 레인 3은 오로볼(orobol) 4 μM 에 SUV 20 kJ/m2 처리군, 레인 4은 제니스테인(genistein) 4 μM 에 SUV 20 kJ/m2 처리군, 레인 5은 제니스틴(genistin) 4 μM 에 SUV 20 kJ/m2 처리군, 레인 6은 다이드제인(daidzein) 4 μM 에 SUV 20 kJ/m2 처리군, 레인 7은 다이드진(daidzin) 4 μM 에 SUV 20 kJ/m2 처리군, 레인 8은 6,7,4'-trihydroxyisoflavone(6-ODI) 4 μM 에 SUV 20 kJ/m2 처리군, 레인 9는 7,3',4'-trihydroxyisoflavone(3'-ODI) 4 μM 에 SUV 20 kJ/m2 처리군, 레인 10은 7,8,4'-trihydroxyisoflavone(8-ODI) 4 M 에 SUV 20 kJ/m2 처리군, 레인 11은 에쿠올(equol) 4 M 에 SUV 20 kJ/m2 처리군이다.
Fig. 1 shows the result of cytotoxicity evaluation by oolone concentration.
Fig. 2 shows the result of evaluation of the expression of MMP-1 protein by ultraviolet light. As a result,
FIG. 3 shows the results of the comparison of the expression levels of MMP-1 protein of 8 kinds of Orobol and isoflavones, wherein
이하, 본 발명의 내용을 하기 실시예를 통해 더욱 상세히 설명하고자 한다. 다만, 본 발명의 권리범위가 하기 실시예에만 한정되는 것은 아니고, 그와 등가의 기술적 사상의 변형까지를 포함한다.
Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the scope of the present invention is not limited to the following embodiments, and includes modifications of equivalent technical ideas.
[제조예 1: 오로볼(orobol)의 제조][Preparation Example 1: Preparation of orobol]
본 제조예에서는 제니스테인(genistein) 및 옥시게나아제(oxygenase (P450, tyrosinase))를 이용하여 오로볼을 생성하고, 이를 수득하고자 하였다. In this example, ourobil was produced using genistein and oxygenase (P450, tyrosinase) to obtain oolobol.
제니스테인(genistein) 및 옥시게나아제(oxygenase (P450, tyrosinase))를 반응시켜, 수산화 반응을 일으켰다. 그 후, 정제수를 이용하여 오로볼 성분을 수득하고, 이를 여과하여 2.5 μM, 5 μM, 10 μM, 20 μM, 40 μM, 80 μM 농도의 오로볼을 최종 수득하였다.
Genistein and oxygenase (P450, tyrosinase) were reacted to cause the hydroxylation reaction. Thereafter, oolop parts were obtained by using purified water, and they were filtered to finally obtain an oolob concentration of 2.5 μM, 5 μM, 10 μM, 20 μM, 40 μM and 80 μM.
[[ 실험예Experimental Example 1: One: 오로볼Orobor (( orobolorobol ) 농도에 따른 세포 독성 측정]Measurement of cytotoxicity by concentration]
본 실험예에서는 인간 각질 형성 세포 모델을 사용하여 상기 제조예 1에서 오로볼의 농도에 따른 세포 독성을 측정하고자 하였다.In this Experimental Example, the cytotoxicity according to the concentration of ourobil in Preparation Example 1 was measured using a human keratinocyte cell model.
DMEM 배지 450 mL에 FBS(Fetal bovine serum) 50 mL를 넣고, 항생제(Penicillin/Streptomycin) 1 mL를 넣어 잘 흔들어 주어 배양용 배지를 제조하였다. 또한, 혈청 기아(serum starvation) 배지로, DMEM 배지를 준비하였다.To 450 mL of DMEM medium, add 50 mL of FBS (Fetal bovine serum), add 1 mL of antibiotic (Penicillin / Streptomycin), and shake well to prepare culture medium. In addition, DMEM medium was prepared with serum starvation medium.
상기 제조예 1의 오로볼을 각 농도별로 배지에 각각 첨가하였다. Orolobil of Preparation Example 1 was added to each medium at each concentration.
그 후, 무균 작업대 안에서 96 웰 플레이트(well plate)를 사용하여 DMSO(Dimethyl sulfoxide)에 녹인 인간 각질 형성 세포를 적절한 수로 배지와 함께 각 100 μl씩 넣어 배양하였다. 세포가 배양 접시에 60% 정도 차면 혈청 기아(serum starvation) 배지에 20시간 배양한 후, 2.5 μM, 5 μM, 10 μM, 20 μM, 40 μM, 80 μM 각 농도별 오로볼을 포함한 배지에서 48시간 동안 배양하였다.Then, human keratinocytes, which were dissolved in DMSO (dimethyl sulfoxide), were added to each well of a 96-well plate in an aseptic workbench with 100 μl of each well. The cells were incubated in a serum starvation medium for 20 hours at a concentration of about 60%, and then cultured in a medium containing 2.5 μM, 5 μM, 10 μM, 20 μM, 40 μM and 80 μM ourobium Lt; / RTI >
48시간 후, MTT(Tetrazolium-based colorimetric) 용액을 10%로 함유한 배지에 3시간 동안 최종 배양하였다. 이때, MTT 용액은 빛에 민감하기 때문에 빛이 없는 곳에서 실험을 진행하였다. 인간 각질 형성 세포를 최종 배양 후, 배지를 쏟아버리고 DMSO(Dimethyl sulfoxide)를 각 웰(well) 당 200 μl씩 넣어 배양 접시 밑에 남아있는 침전물을 녹여주었다.After 48 hours, the cells were cultured for 3 hours in a medium containing 10% MTT (Tetrazolium-based colorimetric) solution. At this time, since the MTT solution is sensitive to light, the experiment was conducted in a place where there is no light. After the human keratinocytes were finally cultured, the medium was poured off and 200 μl of DMSO (dimethyl sulfoxide) was added per well to dissolve the precipitate remaining under the culture dish.
그 후, 'ELISA leader'를 이용하여, 570 nm에서 흡광도를 측정하여 세포 독성을 평가하였으며, 3번 측정한 흡광도의 평균값으로 나타내었다. Thereafter, the cytotoxicity was evaluated by measuring the absorbance at 570 nm using an 'ELISA leader' and expressed as an average value of the absorbance measured 3 times.
실험결과, 오로볼은 20 μM까지 독성을 나타내지 않음을 확인할 수 있었다 (도 1). 따라서, 이를 바탕으로 하기 실험들을 진행하였다.
As a result of the experiment, it was confirmed that the Orobolt did not show any toxicity up to 20 μM (FIG. 1). Therefore, the following experiments were conducted based on this.
[[ 실험예Experimental Example 2: 2: 오로볼(orobol)과With orobol 제니스테인(genistein)의Of genistein 피부 주름 개선 효과 비교 측정] Comparative measurement of skin wrinkle improvement effect]
본 실험예에서는 상기 실험예 1을 통해 정해진 20 μM이하의 농도에서 오로볼(orobol)의 MMP-1 단백질 발현을 평가하고자 하였다. In this Experimental Example, MMP-1 protein expression of orobol was evaluated at a concentration of 20 μM or less determined in Experimental Example 1.
DMEM 배지 450 mL에 FBS(Fetal bovine serum)를 50 mL 넣고, 항생제(Penicillin/Streptomycin)를 1 mL 넣어 잘 흔들어 배양용 배지를 제조하였고, 혈청 기아(serum starvation) 배지로, DMEM 배지를 준비하였다. 50 mL of FBS (Fetal bovine serum) was added to 450 mL of DMEM medium, and 1 mL of antibiotic (Penicillin / Streptomycin) was added to prepare a culture medium for shaking. DMEM medium was prepared with serum starvation medium.
실험을 위해, 인간 각질 형성 세포를 적절한 수로 6 웰 플레이트(well plate)에 배지와 함께 넣어 배양하였다. 세포가 배양 접시에 60% 정도 차면 혈청 기아 배지에서 20시간 동안 배양하였다. For the experiment, human keratinocytes were cultured in an appropriate number of 6 well plates with the medium. When the cells reached about 60% in the culture dish, they were cultured in serum starvation medium for 20 hours.
20시간 배양 후, 세포를 1 μM, 2 μM, 4 μM 농도의 오로볼(orobol)과, 1 μM, 2 μM, 4 μM 농도의 제니스테인(genistein)을 각각 포함한 배지에 배양하여 한 시간 전처리 후, SUV(solar ultra violet) 20 kJ/m2을 조사하여 MMP-1 단백질 발현을 유도하고, 48시간 동안 배양하였다. After 20 hours of incubation, the cells were cultured in a medium containing 1 μM, 2 μM, and 4 μM of orobol and 1 μM, 2 μM, and 4 μM of genistein, respectively, MMP-1 protein expression was induced by irradiation with 20 kJ / m 2 of SUV (solar ultra violet) and cultured for 48 hours.
배양 후, 원심분리를 통해 상층액만 수득하였고, 단백질 정량 키트(Bio-rad Corp., Richmond, CA, USA)를 사용하여 로우리 법(lowry method)으로 정량하였다. 각 농도별 상층액으로부터 얻어진 단백질 약 40 ㎍에 해당하는 단백질을 각각 10% SDS-PAGE에 넣어 전기 영동하여 분리하고, MMP-1 항체를 이용하여 반응시킨 후, 암실에서 ECL 키트(Amersham, Life Science, Denver, USA)를 이용하여 MMP-1 단백질 발현을 확인할 수 있었다.After the culture, only the supernatant was obtained by centrifugation and quantified by the lowry method using a protein quantification kit (Bio-Rad Corp., Richmond, CA, USA). Proteins of about 40 ㎍ of protein obtained from each supernatant were separated by electrophoresis in 10% SDS-PAGE, and reacted using MMP-1 antibody. Then, ECL kit (Amersham, Life Science , Denver, USA) was used to confirm the expression of MMP-1 protein.
실험결과, SUV(solar ultra violet) 로 인해 유도된 MMP-1 단백질 발현이 제니스테인(genistein) 처리군 보다 오로볼(orobol) 처리군에서 크게 감소하는 것을 확인하였다 (도 2). 이러한 결과로, 오로볼(orobol)의 피부 주름 개선 효능이 제니스테인(genistein)보다 우수한 것을 확인할 수 있었다.
As a result, it was confirmed that the expression of MMP-1 protein induced by SUV (solar ultra violet) was greatly reduced in the group treated with orobol than the group treated with genistein (FIG. 2). As a result, it was confirmed that the effect of improving the skin wrinkles of orobol was superior to that of genistein.
[[ 실험예Experimental Example 3: 3: 오로볼(orobol)과With orobol 이소플라본 8종의 피부 주름 개선 효과 비교] Comparison of the effect of improving the skin wrinkles of 8 isoflavones]
본 실험예에서는 오로볼(orobol)과 제니스테인(genistein)을 포함하는 이소플라본 8의 피부 주름개선 효과를 비교하고자 하였다.In this experiment, the effect of
이소플라본 8종은 제니스테인(genistein), 다이드제인(daidzein), 배당체인 제니스틴(genistin), 배당체인 다이드진(daidzin), 대사체인 6,7,4'-trihydroxyisoflavone(6-ODI), 대사체인 7,3',4'-trihydroxyisoflavone(3'-ODI), 대사체인 7,8,4'-trihydroxyisoflavone(8-ODI), 대사체인 에쿠올(equol)을 사용하였으며, 각각 4 μM의 농도를 사용하였다. 그 외 실험 방법은 실험예 2와 동일하게 진행하였다.The eight isoflavones include genistein, daidzein, glycoside genistin, glycoside daidzin, the
실험결과, SUV로 인해 유도된 MMP-1 단백질 발현은 제니스테인(genistein), 다이드제인(daidzein), 제니스틴(genistin), 다이드진(daidzin), 6,7,4'-trihydroxyisoflavone(6-ODI), 7,3',4'-trihydroxyisoflavone(3'-ODI), 7,8,4'-trihydroxyisoflavone(8-ODI), 에쿠올(equol) 처리군 보다 오로볼(orobol) 처리군에서 더 크게 감소하는 것을 확인할 수 있었다 (도 3). As a result of the experiment, the SUV-induced MMP-1 protein expression was detected by genistein, daidzein, genistin, daidzin, 6,7,4'-trihydroxyisoflavone (6-ODI ), 7,3 ', 4'-trihydroxyisoflavone (3'-ODI), 7,8,4'-trihydroxyisoflavone (8-ODI), orobol treated group than the equol treated group (Fig. 3).
이러한 결과로, 오로볼(orobol)의 피부 주름 개선 효능이 상기 이소플라본 8종 보다 더 우수한 것을 확인할 수 있었다.
As a result, it was confirmed that the effect of improving the skin wrinkles of orobol was better than that of the isoflavones.
[실시[practice 예Yes 1: 피부 주름 개선용 식품 조성물 제조] 1: Preparation of food composition for improving skin wrinkles]
본 실시예에서는 하기와 같이 피부 주름 개선용 식품 조성물을 제조하였다. In this Example, a food composition for improving skin wrinkles was prepared as follows.
(1) 선식 제조 (1) Manufacturing of wire
현미, 보리, 찹쌀, 율무를 공지의 방법으로 알파화시켜 건조시킨 것을 배전한 후 분쇄기로 입도 60메쉬의 분말로 준비하였다. 검정콩, 검정깨 및 들깨 각각을 공지의 방법으로 쪄서 건조시킨 후 배전 및 분쇄하여 입도 60메쉬의 분말로 준비하였다. 이후, 현미 30 중량%, 율무 15 중량%, 보리 20 중량%, 찹쌀 9 중량%, 들깨 7 중량%, 검정콩 8 중량%, 검정깨 7 중량%, 오로볼(orobol) 3 중량%, 영지 0.5 중량% 및 지황 0.5 중량%을 혼합하여 선식을 제조하였다.Brown rice, barley, glutinous rice, and yulmu were dried by a known method and dried, and then the mixture was prepared into powder having a particle size of 60 mesh by a pulverizer. Black beans, black sesame seeds and perilla seeds were each steamed and dried by known methods, and then power distribution and pulverization were carried out to prepare powder having a particle size of 60 mesh. Thereafter, 30% by weight of brown rice, 15% by weight of yulmu, 20% by weight of barley, 9% by weight of glutinous rice, 7% by weight of perilla seeds, 8% by weight of black beans, 7% by weight of black sesame, 3% by weight of orobol, % And 0.5 wt% of sulfuric acid were mixed to prepare an electric wire.
(2) 츄잉껌 제조(2) Production of chewing gum
껌 베이스 20 중량%, 설탕 76.9 중량%, 향료 1 중량%, 물 2 중량% 및 오로볼(orobol) 0.1 중량%를 배합하여 통상의 방법으로 츄잉껌을 제조하였다.Chewing gum was prepared in a conventional manner by mixing 20% by weight of a gum base, 76.9% by weight of sugar, 1% by weight of a flavor, 2% by weight of water and 0.1% by weight of orobol.
(3) 캔디 제조(3) Candy manufacturing
설탕 60 중량%, 물엿 39.8 중량%, 향료 0.1 중량% 및 오로볼(orobol) 0.1 중량%를 배합하여 통상의 방법으로 캔디를 제조하였다.Sugar, 60% by weight of sugar, 39.8% by weight of starch syrup, 0.1% by weight of fragrance and 0.1% by weight of orobol were prepared.
(4) 비스킷 제조(4) Manufacturing of biscuits
박력 1급 25.59 중량%, 중력 1급 22.22 중량%, 정백당 4.80 중량%, 식염 0.73 중량%, 포도당 0.78 중량%, 팜쇼트닝 11.78 중량%, 암모니움 1.54 중량%, 중조 0.17 중량%, 중아황산나트륨 0.16 중량%, 쌀가루 1.45 중량%, 비타민 B1 0.0001 중량%, 비타민 B2 0.0001 중량%, 밀크향 0.04 중량%, 물 20.6998 중량%, 전지분유 1.16 중량%, 대용분유 0.29 중량%, 제일인산칼슘 0.03 중량%, 살포염 0.29 중량% 및 분무유 7.27 중량%와 오로볼(orobol) 0.9중량%를 배합하여 통상의 방법으로 비스킷을 제조하였다. By weight of starch, 0.77% by weight of glucose, 0.78% by weight of glucose, 11.78% by weight of palm shortening, 1.54% by weight of ammonia, 0.17% by weight of sodium bicarbonate, 0.16% by weight of sodium bisulfite 1.45 wt% of rice flour, 0.0001 wt% of vitamin B 1, 0.0001 wt% of vitamin B 2 , 0.04 wt% of milk fractions, 20.6998 wt% of water, 1.16 wt% of whole milk powder, 0.29 wt% 0.29% by weight of spray salt, 7.27% by weight of spray oil and 0.9% by weight of orobol were mixed to prepare a biscuit by a conventional method.
(5) 건강음료 제조(5) health drink manufacturing
꿀 0.26 중량%, 치옥토산아미드 0.0002 중량%, 니코틴산아미드 0.0004 중량%, 염산리보플라빈나트륨 0.0001 중량%, 염산피리독신 0.0001 중량%, 이노시톨 0.001 중량%, 오르트산 0.002 중량%, 물 98.7362 중량% 및 오로볼(orobol) 1.0 중량%를 배합하여 통상의 방법으로 건강 음료를 제조하였다.0.0001 wt.% Of niacinamide, 0.0001 wt.% Of sodium riboflavin, 0.0001 wt.% Of pyridoxine hydrochloride, 0.001 wt.% Of inositol, 0.002 wt.% Of orthoacetic acid, 98.7362 wt.% Of water, and 1.0% by weight of orobol were mixed to prepare a health drink.
(6) 소시지 제조(6) Production of sausages
돈육 65.18 중량%, 계육 25 중량%, 전분 3.5 중량%, 대두단백 1.7 중량%, 식염 1.62 중량%, 포도당 0.5 중량% 및 글리세린 1.5 중량%와 오로볼(orobol) 1.0 중량%를 배합하여 통상의 방법으로 소시지를 제조하였다.The mixture was mixed with 65.18% by weight of pork, 25% by weight of chicken meat, 3.5% by weight of starch, 1.7% by weight of soybean protein, 1.62% by weight of salt, 0.5% by weight of glucose and 1.5% by weight of glycerin and 1.0% To prepare sausages.
(7) 정제형 건강보조식품 제조(7) Manufacture of tablets
스피루리나 55 중량%, 구아검효소 분해물 10 중량%, 비타민 B 염산염 0.01중량%, 비타민 B6 염산염 0.01 중량%, DL-메티오닌 0.23 중량%, 스테아린산 마그네슘 0.7 중량%, 유당 22.2 중량% 및 옥수수전분 1.85 중량%와 오로볼(orobol) 10중량%를 배합하여 통상의 방법으로 정제형 건강보조식품을 제조하였다.Spirulina 55% by weight, guar gum enzyme degradation product of 10 wt%, Vitamin B hydrochloride 0.01% by weight vitamin B 6 hydrochloride 0.01%, DL- methionine, 0.23% by weight, magnesium stearate 0.7% by weight, lactose 22.2% by weight of corn starch 1.85 wt. And 10% by weight of orobol were mixed to prepare a refillable health supplement.
(8) 주류 제조(8) Liquor production
오로볼 0.5 중량%를 소주, 맥주, 양주 또는 과실주와 혼합하여 에멀전 상태로 만든 후, 진공상태에서 7,000 rpm으로 15분간 원심분리하거나 고속믹서기로 9,000 rpm에서 혼합하여 오로볼(orobol)이 함유된 주류를 제조하였다.
0.5% by weight of oolobol was mixed with soju, beer, liquor or fruit wine to make an emulsion state, and the mixture was centrifuged at 7,000 rpm for 15 minutes under a vacuum condition or mixed at 9,000 rpm with a high-speed mixer to prepare a liquor containing orobol .
[실시[practice 예Yes 2: 피부 주름 개선용 2: for skin wrinkle improvement 화장료Cosmetics 조성물 제조] Composition Preparation]
본 실시예에서는 하기 표 1에 기재된 조성대로 피부 주름 개선용 화장료 조성물(로션)을 제조하였다.In this Example, a cosmetic composition (lotion) for improving skin wrinkles was prepared according to the composition shown in Table 1 below.
Claims (6)
[화학식 1]
Genistein is oxidized using oxygenase to produce an orobol represented by the following formula (1) and then added to a cosmetic composition. The oolorb has a concentration of 2 to 4 μM ≪ / RTI > wherein the cosmetic composition is a cosmetic composition for improving skin wrinkles.
[Chemical Formula 1]
상기 피부 주름 개선용 화장료 조성물은,
현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 팩, 마사지크림 및 스프레이 중 선택되는 어느 하나인 것을 특징으로 하는 피부 주름 개선용 화장료 조성물의 제조방법.
5. The method of claim 4,
In the cosmetic composition for improving skin wrinkles,
The composition is any one selected from suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, surfactant-containing cleansers, oils, powder foundations, emulsion foundations, wax foundations, packs, massage creams and sprays Wherein the cosmetic composition is a cosmetic composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150044622A KR101602629B1 (en) | 2015-03-30 | 2015-03-30 | Producing method of a composition with orobol for treating wrinkled skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150044622A KR101602629B1 (en) | 2015-03-30 | 2015-03-30 | Producing method of a composition with orobol for treating wrinkled skin |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101602629B1 true KR101602629B1 (en) | 2016-03-11 |
Family
ID=55583047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150044622A KR101602629B1 (en) | 2015-03-30 | 2015-03-30 | Producing method of a composition with orobol for treating wrinkled skin |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101602629B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101983570B1 (en) | 2018-01-31 | 2019-05-29 | 서울대학교 산학협력단 | Lipid nano particle composition for improvement of orobol stability and method for production of it |
KR20200073665A (en) | 2018-12-14 | 2020-06-24 | 서울대학교산학협력단 | Food composition and pharmaceutical composition for improvement, prevention or treatment of diarrhea and antidiarrhotica with orobol |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100530199B1 (en) | 2000-11-10 | 2005-11-22 | 로레알 | Cosmetic composition comprising an aminophenol derivative and an isoflavonoid |
KR101314689B1 (en) | 2005-06-29 | 2013-10-07 | 디에스엠 아이피 어셋츠 비.브이. | Topical compositions comprising nanoparticles of an isoflavone |
US20140148401A1 (en) * | 2011-04-19 | 2014-05-29 | Laboratoires Inneov | Combination of carotenoid, phytooestrogen and vitamin c for moisturizing the skin |
KR20150001169A (en) * | 2013-06-26 | 2015-01-06 | 서울대학교산학협력단 | Catechol derivatives prepared by using tyrosinase, method for preparation thereof, and application thereof |
-
2015
- 2015-03-30 KR KR1020150044622A patent/KR101602629B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100530199B1 (en) | 2000-11-10 | 2005-11-22 | 로레알 | Cosmetic composition comprising an aminophenol derivative and an isoflavonoid |
KR101314689B1 (en) | 2005-06-29 | 2013-10-07 | 디에스엠 아이피 어셋츠 비.브이. | Topical compositions comprising nanoparticles of an isoflavone |
US20140148401A1 (en) * | 2011-04-19 | 2014-05-29 | Laboratoires Inneov | Combination of carotenoid, phytooestrogen and vitamin c for moisturizing the skin |
KR20150001169A (en) * | 2013-06-26 | 2015-01-06 | 서울대학교산학협력단 | Catechol derivatives prepared by using tyrosinase, method for preparation thereof, and application thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101983570B1 (en) | 2018-01-31 | 2019-05-29 | 서울대학교 산학협력단 | Lipid nano particle composition for improvement of orobol stability and method for production of it |
KR20200073665A (en) | 2018-12-14 | 2020-06-24 | 서울대학교산학협력단 | Food composition and pharmaceutical composition for improvement, prevention or treatment of diarrhea and antidiarrhotica with orobol |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5577443B2 (en) | Extract of rose placenta tissue culture and method for producing the same | |
JP2004067590A (en) | Female sex hormone production promoter and skin preparation for external use containing the same | |
KR101602629B1 (en) | Producing method of a composition with orobol for treating wrinkled skin | |
KR20170136958A (en) | Composition for skin improvement comprising multiple extract | |
KR101964837B1 (en) | Composition for improving skin wrinkle comprising Cynomorium songaricum extract or its fraction as effective component | |
KR20170136957A (en) | Composition for skin improvement comprising multiple extract | |
KR20170078259A (en) | Composition for improving skin conditions comprising Isosteviol | |
KR20160020242A (en) | Cosmetic or pharmaceutical composition for melanism, elasticity, anti-wrinkle, or skin moisturizing comprising parthenolide | |
KR20170079977A (en) | Composition for improving skin conditions comprising Praeruptorin A | |
KR102629001B1 (en) | Composition for skin improvement containing diosbulbin B | |
KR20160020246A (en) | Cosmetic or pharmaceutical composition for melanism, elasticity, anti-wrinkle, or skin moisturizing comprising dehydrocorydaline or a pharmaceutically acceptable salt thereof | |
KR20160020253A (en) | Cosmetic or pharmaceutical composition for skin whitening, elasticity, anti-wrinkle, or skin moisturizing comprising atractylenolide I | |
KR102348148B1 (en) | Cosmetic or pharmaceutical composition for melanism, elasticity, anti-wrinkle, or skin moisturizing comprising dihydroartemisinin | |
KR102543123B1 (en) | Composition for skin moisturizing comprising Aloe flower extract thereof as an active ingredient | |
KR102600558B1 (en) | Composition for promoting hair growth and preventing hair loss comprising atraric acid | |
KR101454515B1 (en) | Composition for improving skin conditions comprising veratric acid or pharmaceutically acceptable salt thereof as an active ingredient | |
KR20170076429A (en) | Composition for improving skin conditions comprising Polygalasaponin F | |
KR102601551B1 (en) | Composition for skin improvement containing liriopesides B | |
KR102665308B1 (en) | Composition for skin improvement containing rebaudioside A | |
KR20170080084A (en) | Composition for improving skin conditions comprising nepodin | |
CN116650378A (en) | Application of tartary buckwheat extract in preparation of product for improving skin elasticity and wrinkles | |
KR20160020250A (en) | Cosmetic or pharmaceutical composition for skin whitening, elasticity, anti-wrinkle, or skin moisturizing comprising Wogonoside or a pharmaceutically acceptable salt thereof | |
KR20210118272A (en) | A composition comprising kakkalide | |
KR20180069529A (en) | Cosmetic Composition for skin moisturizing comprising Vitex rotundifolia Linne fil. Fruit extracts | |
KR20170076418A (en) | Composition for improving skin conditions comprising dictamnine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20190109 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20200102 Year of fee payment: 5 |